As previously reported, Guggenheim analyst Joseph Osha downgraded Itron (ITRI) to Neutral from Buy and removed the firm’s prior “admittedly stale” $155 price target Following a reassessment of the near-term growth trajectory, the firm is reducing its 2026 and 2027 earnings estimates given its view that an uncertain environment is likely to persist through 2026.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ITRI:
- Itron downgraded to Neutral from Buy at Guggenheim
- Itron,Toumetis partner to reduce wildfire risk in Southern California
- Itron, PG&E expand collaboration to create more reliable, flexible grid
- Itron to showcase latest advancements with Grid Edge Intelligence portfolio
- AI Daily: SoftBank in discussions to invest up to $30B more in OpenAI